News | Artificial Intelligence | May 31, 2024

InfoBionic.Ai and HBox.ai Ink Partnership to Offer the First AI-Driven "Cardiology Clinic of the Future"

This collaboration integrates HBox.ai's virtual care model with InfoBionic.AI's advanced cardiac telemetry, offering AI-driven tools for virtual consults, remote monitoring, and diagnostic care

This collaboration integrates HBox.ai's virtual care model with InfoBionic.AI's advanced cardiac telemetry, offering AI-driven tools for virtual consults, remote monitoring, and diagnostic care

May 31, 2024 — InfoBionic.ai and HBox.ai announced a groundbreaking partnership that brings together the leading AI-driven technology platforms from both companies to offer the first comprehensive cardiovascular care solution for the "Cardiology Clinic of the Future." 

HBox.ai, known for its unique "Virtual Clinic in a Clinic" model, provides an AI-driven technology platform and services enabling cardiology practices to offer virtual care services to their patients while generating new recurring revenue streams. InfoBionic.Ai delivers state-of-the-art AI enabled cardiac telemetry solutions to cardiology practices nationwide. InfoBionic.Ai’s gold-standard approach consolidates the virtual telemetry service line into a highly efficient and clinically superior tool. With flexible business models, partners can seamlessly integrate their solution in a way that best fits their existing infrastructure and workflow. 

This unique partnership enables both companies to create the cardiovascular care industry's first integrated AI-Driven Virtual Consult, RPM, Chronic Care and diagnostic cardiac monitoring solution, empowering the creation of the "Cardiology Clinic of the Future." By combining their deep and wide datasets with their AI expertise, HBox.ai and InfoBionic.Ai aim to create an end-to-end view of a cardiac patient's condition, providing healthcare providers with unparalleled clinical insights.  

HBox.ai and InfoBionic.Ai are elevating cardiovascular care by providing new and more effective tools for doctors to diagnose and predict risk. Beyond clinical care, this partnership will deploy AI in all aspects of care delivery including patient engagement and bringing operational efficiency to Cardiology outpatient centers. Ultimately, the goal is reduced hospitalizations and improved outcomes for patients.

"At InfoBionic.Ai, we believe that partnering with HBox.ai will deliver unmatched value to cardiology practices nationwide. Our combined AI capabilities will enable us to offer healthcare providers a unique, comprehensive solution, empowering them to deliver the highest quality care for their patients. This partnership embodies our shared vision of revolutionizing cardiovascular care with the 'Cardiology Clinic of the Future.'" said Stuart Long, CEO of InfoBionic.ai

"We see tremendous synergy between HBox.ai and Infobionic.ai that will enable us to create a one-of-a-kind cardiology platform benefiting both patients and providers. HBox.ai is excited to collaborate with InfoBionic.ai to move beyond our current go-to-market partnership and develop a fully integrated, AI-driven model that promises innovation in both product and business models for cardiovascular outpatient centers." said CEO of HBox.ai Banuprasad Dhanakoti.

For more information: https://infobionic.ai


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now